Latest news
CYTK Q2 Earnings Top Estimates, Myqorzo Uptake Strong - TradingViewTradingView · Fri, 07 Aug 2026 18:22:00 GMTHow Investors May Respond To Cytokinetics (CYTK) UK MYQORZO Approval Amid Wider Quarterly Loss - simplywall.stsimplywall.st · Fri, 07 Aug 2026 06:17:25 GMTCytokinetics, Incorporated (CYTK) latest stock news and headlines – Yahoo Finance - Yahoo Finance SingaporeYahoo Finance Singapore · Fri, 07 Aug 2026 00:16:11 GMTCytokinetics (CYTK) Releases Q2 2026 Earnings: Revenue Beats but Losses Persist - Quiver QuantitativeQuiver Quantitative · Thu, 06 Aug 2026 21:10:00 GMTCytokinetics (NASDAQ:CYTK) Beats Q2 Estimates on Strong MYQORZO Launch - ChartMillChartMill · Thu, 06 Aug 2026 20:49:51 GMTCYTOKINETICS INC Q2 2026: Revenue $28.6M, EPS $(1.50) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:35:07 GMTCytokinetics reports Q2 2026: $28.6M revenue, $1.7B cash, $198.8M net loss - TradingViewTradingView · Thu, 06 Aug 2026 20:13:04 GMTCytokinetics Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 20:00:00 GMT